---

layout: post
category: press
title: "InterVenn Biosciences raises $34 million to accelerate diagnostic cancer test development with AI"
date: 2020-11-16 14:16:26
link: https://vrhk.co/35yaT52
image: https://venturebeat.com/wp-content/uploads/2020/04/6508d40a-448c-44b3-bd7d-3ec135ba2e54-e1585776810679.png?w=1200&strip=all
domain: venturebeat.com
author: "VentureBeat"
icon: https://venturebeat.com/wp-content/themes/vb-news/img/favicon.ico
excerpt: "InterVenn Biosciences, a company developing an AI-imbued platform for diagnostic cancer test design, raised $34 million."

---

### InterVenn Biosciences raises $34 million to accelerate diagnostic cancer test development with AI

InterVenn Biosciences, a company developing an AI-imbued platform for diagnostic cancer test design, raised $34 million.